Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-blind Placebo-controlled Trial
- PMID: 28943228
- PMCID: PMC5652021
- DOI: 10.1016/j.ebiom.2017.09.013
Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-blind Placebo-controlled Trial
Abstract
Background: Probiotics may help to prevent symptoms of anxiety and depression through several putative mechanisms.
Objective: The aim of this study was to evaluate the effect of Lactobacillus rhamnosus HN001 (HN001) given in pregnancy and postpartum on symptoms of maternal depression and anxiety in the postpartum period. This was a secondary outcome, the primary outcome being eczema in the offspring at 12months of age.
Design, setting, participants: A randomised, double-blind, placebo-controlled trial of the effect of HN001 on postnatal mood was conducted in 423 women in Auckland and Wellington, New Zealand. Women were recruited at 14-16weeks gestation.
Intervention: Women were randomised to receive either placebo or HN001 daily from enrolment until 6months postpartum if breastfeeding.
Outcome measures: Modified versions of the Edinburgh Postnatal Depression Scale and State Trait Anxiety Inventory were used to assess symptoms of depression and anxiety postpartum.
Trial registration: Australia NZ Clinical Trials Registry: ACTRN12612000196842.
Findings: 423 women were recruited between December 2012 and November 2014. 212 women were randomised to HN001 and 211 to placebo. 380 women (89.8%) completed the questionnaire on psychological outcomes, 193 (91.0%) in the treatment group and 187 (88.6%) in the placebo group. Mothers in the probiotic treatment group reported significantly lower depression scores (HN001 mean=7·7 (SD=5·4), placebo 9·0 (6·0); effect size -1·2, (95% CI -2·3, -0·1), p=0·037) and anxiety scores (HN001 12·0 (4·0), placebo 13·0 (4·0); effect size -1·0 (-1·9, -0·2), p=0·014) than those in the placebo group. Rates of clinically relevant anxiety on screening (score>15) were significantly lower in the HN001 treated mothers (OR=0·44 (0·26, 0·73), p=0·002).
Interpretation: Women who received HN001 had significantly lower depression and anxiety scores in the postpartum period. This probiotic may be useful for the prevention or treatment of symptoms of depression and anxiety postpartum.
Funding source: Health Research Council of New Zealand (11/318) and Fonterra Co-operative Group Ltd.
Keywords: Anxiety; Depression; Microbiome-gut-brain axis; Probiotic; Randomised controlled trial.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.
Figures
Comment in
-
Quo Vadis, Probiotics? Human Research Supports Further Study of Beneficial Microbes in Mental Health.EBioMedicine. 2017 Oct;24:14-15. doi: 10.1016/j.ebiom.2017.09.019. Epub 2017 Sep 18. EBioMedicine. 2017. PMID: 28958605 Free PMC article. No abstract available.
Similar articles
-
The Probiotics in Pregnancy Study (PiP Study): rationale and design of a double-blind randomised controlled trial to improve maternal health during pregnancy and prevent infant eczema and allergy.BMC Pregnancy Childbirth. 2016 Jun 3;16(1):133. doi: 10.1186/s12884-016-0923-y. BMC Pregnancy Childbirth. 2016. PMID: 27255079 Free PMC article. Clinical Trial.
-
Early pregnancy probiotic supplementation with Lactobacillus rhamnosus HN001 may reduce the prevalence of gestational diabetes mellitus: a randomised controlled trial.Br J Nutr. 2017 Mar;117(6):804-813. doi: 10.1017/S0007114517000289. Epub 2017 Apr 3. Br J Nutr. 2017. PMID: 28367765 Free PMC article. Clinical Trial.
-
Maternal supplementation alone with Lactobacillus rhamnosus HN001 during pregnancy and breastfeeding does not reduce infant eczema.Pediatr Allergy Immunol. 2018 May;29(3):296-302. doi: 10.1111/pai.12874. Epub 2018 Apr 6. Pediatr Allergy Immunol. 2018. PMID: 29415330 Clinical Trial.
-
Antidepressant treatment with sertraline for adults with depressive symptoms in primary care: the PANDA research programme including RCT.Southampton (UK): NIHR Journals Library; 2019 Dec. Southampton (UK): NIHR Journals Library; 2019 Dec. PMID: 31869013 Free Books & Documents. Review.
-
Selenium Intake and Postnatal Depression-A Short Review.Nutrients. 2024 Jun 18;16(12):1926. doi: 10.3390/nu16121926. Nutrients. 2024. PMID: 38931280 Free PMC article. Review.
Cited by
-
Probiotic treatment causes sex-specific neuroprotection after traumatic brain injury in mice.Res Sq [Preprint]. 2024 Apr 2:rs.3.rs-4196801. doi: 10.21203/rs.3.rs-4196801/v1. Res Sq. 2024. PMID: 38645104 Free PMC article. Preprint.
-
Probiotics Supplementation during Pregnancy: Can They Exert Potential Beneficial Effects against Adverse Pregnancy Outcomes beyond Gestational Diabetes Mellitus?Biology (Basel). 2024 Feb 28;13(3):158. doi: 10.3390/biology13030158. Biology (Basel). 2024. PMID: 38534428 Free PMC article.
-
Intestinal microbiome and maternal mental health: preventing parental stress and enhancing resilience in mothers.Commun Biol. 2024 Feb 29;7(1):235. doi: 10.1038/s42003-024-05884-5. Commun Biol. 2024. PMID: 38424440 Free PMC article.
-
Mood and microbes: a comprehensive review of intestinal microbiota's impact on depression.Front Psychiatry. 2024 Feb 9;15:1295766. doi: 10.3389/fpsyt.2024.1295766. eCollection 2024. Front Psychiatry. 2024. PMID: 38404464 Free PMC article. Review.
-
Maternal mood, anxiety and mental health functioning after combined myo-inositol, probiotics, micronutrient supplementation from preconception: Findings from the NiPPeR RCT.Psychiatry Res. 2024 Apr;334:115813. doi: 10.1016/j.psychres.2024.115813. Epub 2024 Feb 23. Psychiatry Res. 2024. PMID: 38402742 Free PMC article. Clinical Trial.
References
-
- Abbott M.W., Williams M.M. Postnatal depressive symptoms among Pacific mothers in Auckland: prevalence and risk factors. Aust. N. Z. J. Psychiatry. 2006;40:230–238. - PubMed
-
- Akkasheh G., Kashani-Poor Z., Tajabadi-Ebrahimi M. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Nutrition. 2016;32:315–320. - PubMed
-
- Barrera-Bugueño C., Realini O., Escobar-Luna J., Sotomayor-Zarate R., Gotteland M., Julio-Pieper M., Bravo J.A. Anxiogenic effects of a lactobacillus, inulin and the synbiotic on healthy juvenile rats. Neuroscience. 2017;359:18–29. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical